News | RIVM

More people getting tested if they have symptoms, staying home remains difficult

Since the recent resurgence of the novel coronavirus, more people perceive the virus as threatening. At the same time, support for the measures has increased and people are following the behavioural recommendations more closely.

Gap between intention and behaviour in staying home and testing for COVID-19

The Dutch policy of staying home and getting tested if you have corona-related symptoms can count on support from the majority of the over 50,000 participants in RIVM’s behavioural study.

Many people willing to isolate at home in case of positive COVID-19 test

The sense of threatening danger from the novel coronavirus is declining. People are feeling less anxious and despondent than in the initial phase of the coronavirus pandemic.

Staying 1.5 metres apart is growing more difficult

Staying 1.5 metres apart seems to be more and more difficult for people to manage.

The 1.5-metre society is difficult to maintain

Personal hygiene measures, such as not shaking hands, or using paper tissues, are not considered a problem by most Dutch people.

State Secretary Blokhuis: boys will also be vaccinated against HPV virus

The vaccine against the HPV human papillomavirus virus will also become available for boys.

Research: HPV vaccine is safe

RIVM research shows no causal link between the vaccine against cervical cancer (HPV) and long-term fatigue symptoms in girls.

Vaccination rate again drops slightly, HPV vaccination rate drops considerably

The vaccination rate for vaccines included in the National Immunisation Programme has dropped slightly by about 1 percent.

RIVM and Olive Foundation open trading to mark the European Cervical Cancer Prevention Week

January 20th, the Olive Foundation and RIVM opened AEX trading day in Amsterdam on the occasion of the 9th European Cervical Cancer Prevention Week.

The National Immunisation Programme in the Netherlands 2013 - 2014

Every year, RIVM provides an overview of surveillance and developments in the National Immunisation Programme (NIP).